Fulton Breakefield Broenniman d/b/a FBB Capital Partners »

Phathom Pharmaceuticals shares owned by Fulton Breakefield Broenniman d/b/a FBB Capital Partners

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Fulton Breakefield Broenniman d/b/a FBB Capital Partners from 13F filings

Historical chart of Fulton Breakefield Broenniman d/b/a FBB Capital Partners investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by Fulton Breakefield Broenniman d/b/a FBB Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by Fulton Breakefield Broenniman d/b/a FBB Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $215k 24k 9.13

More positions owned by Fulton Breakefield Broenniman d/b/a FBB Capital Partners

Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Us Aggbd Et (AGG)
Amazon (AMZN)
UnitedHealth (UNH)
Ishares Tr Core S&p Mcp Etf (IJH)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Progressive Corporation (PGR)
Lowe's Companies (LOW)
Spdr Ser Tr Bbg Conv Sec Etf (CWB)
Danaher Corporation (DHR)

View all positions for Fulton Breakefield Broenniman d/b/a FBB Capital Partners

Top funds holding Phathom Pharmaceuticals

Frazier Life Sciences Management
Medicxi Ventures Management
Carlyle
NEA Management Company
Vanguard Group
Avidity Partners Management
Gilder, Gagnon, Howe & Co
683 Capital Management
Decheng Capital
Newtyn Management
Jacobs Levy Equity Management
Kennedy Capital Management
Jennifer Ranahan
Propel Bio Management
Checkpoint Capital

View all funds holding Phathom Pharmaceuticals